MRS4596, a potent and selective antagonist of the P2X4 receptor, exhibits an IC50 of 1.38 µM for the human P2X4 receptor. This compound demonstrates both neuroprotective and neuro-rehabilitative effects in ischemic stroke models, making it valuable for research purposes in the context of ischemic stroke.
Molecular Weight:
439.42
Formula:
C21H14N5NaO3S
Target:
P2X Receptor|||Others
T73452
* VAT and and shipping costs not included. Errors and price changes excepted
